Trinucleotide repeat length and progression of illness in Huntington's disease.
Open Access
- 1 November 1994
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 31 (11) , 872-874
- https://doi.org/10.1136/jmg.31.11.872
Abstract
The genetic defect causing Huntington's disease (HD) has been identified as an unstable expansion of a trinucleotide (CAG) repeat sequence within the coding region of the IT15 gene on chromosome 4. In 50 patients with manifest HD who were evaluated prospectively and uniformly, we examined the relationship between the extent of the DNA expansion and the rate of illness progression. Although the length of CAG repeats showed a strong inverse correlation with the age at onset of HD, there was no such relationship between the number of CAG repeats and the rate of clinical decline. These findings suggest that the CAG repeat length may influence or trigger the onset of HD, but other genetic, neurobiological, or environmental factors contribute to the progression of illness and the underlying pace of neuronal degeneration.Keywords
This publication has 12 references indexed in Scilit:
- Huntington's disease in Grampian region: correlation of the CAG repeat number and the age of onset of the disease.Journal of Medical Genetics, 1993
- Mutation size and age at onset in Huntington's disease.Journal of Medical Genetics, 1993
- Molecular analysis and clinical correlations of the Huntington's disease mutationThe Lancet, 1993
- Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15Human Molecular Genetics, 1993
- The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's diseaseNature Genetics, 1993
- Trinucleotide repeat length instability and age of onset in Huntington's diseaseNature Genetics, 1993
- Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's diseaseNature Genetics, 1993
- A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomesMolecular and Cellular Probes, 1993
- Duration of illness in Huntington's disease is not related to age at onset.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- A controlled clinical trial of baclofen as protective therapy in early huntington's diseaseAnnals of Neurology, 1989